Profusa (NASDAQ: PFSA) Moves Listing to Nasdaq Capital Market

May 15, 2026

Key Developments Profusa (NASDAQ: PFSA), a company advancing digital health technology for continuous biochemical monitoring, has announced a significant update regarding its stock listing. As of May 15, 2026, Profusa’s shares will be officially transferred to trading on The Nasdaq Capital Market. This move to The Nasdaq Capital Market reflects the company’s progress and growth in the digital health sector, positioning it within a respected marketplace that may provide enhanced…

Read More >>

Nova Minerals (NASDAQ: NVA) Announces Quarterly Update Webinar Invitation

May 15, 2026

Market Overview Nova Minerals Limited (NASDAQ: NVA) operates within the minerals exploration sector and remains on investors’ radar as it continues to develop its portfolio. The stock’s performance is closely watched given the company’s growing efforts to expand its resource base and visibility in the market. Investors in Nova Minerals Limited (NASDAQ: NVA) often seek timely updates to gauge the company’s progress and strategic direction, particularly as market conditions fluctuate…

Read More >>

Duke Robotics Corp. (NASDAQ: DUKR) Announces $9.2 Million Offering and NASDAQ Uplisting

May 14, 2026

Key Developments Duke Robotics Corp. (NASDAQ: DUKR) has announced the pricing of its underwritten public offering for 1,125,000 units at $8.20 per unit. Each unit is composed of one share of common stock and one warrant, which entitles holders to purchase an additional share at $8.60, with a five-year expiration period. The stock and warrants will be issued separately and are expected to start trading on the Nasdaq Capital Market…

Read More >>

Iron Dome Acquisition I Corp. (NASDAQ: IDACU) Prices $150 Million IPO

May 14, 2026

Key Developments Iron Dome Acquisition I Corp. has announced the pricing of its initial public offering (IPO), setting the price at $10.00 per unit. The offering comprises 15 million units, with each unit including one Class A ordinary share and one half of one redeemable warrant. This public offering represents a significant milestone for Iron Dome Acquisition I Corp. as it prepares for entry into the public markets. Trading is…

Read More >>

LIXTE Biotechnology (NASDAQ: LIXT) Reports Q1 2026 Results and Operational Progress

May 14, 2026

Expert Analysis LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) is making notable strides in its clinical-stage operations, focusing on innovative cancer therapies. The company’s recent filing offers deeper insight into its ongoing development efforts, financial standing, and strategic priorities within the competitive biopharmaceutical space. Investors and analysts closely monitoring LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) will find the quarterly report valuable for understanding the company’s commitment to advancing novel treatments and…

Read More >>

Bio Green Med Solution (NASDAQ: BGMS) Reports Q1 Financial Results and Business Update

May 14, 2026

Expert Analysis Bio Green Med Solution, Inc. (NASDAQ: BGMS) operates primarily within the fire safety protection and distribution sector, marking an important position in diversified services. The Company’s recent first quarter financial results give insight into its operational efficiency and strategic direction moving forward. Analysts emphasize that BGMS’s ongoing execution in its key segments could significantly influence its market stability and investor confidence. The Q1 report highlights how Bio Green…

Read More >>

Adaptin Bio (OTCQB: APTN) Starts Trading on OTCQB Market

May 14, 2026

Expert Analysis Adaptin Bio (OTCQB: APTN) entering the OTCQB Venture Market marks a strategic milestone in expanding its investor base and market presence. This transition highlights the company’s commitment to increasing liquidity and offering enhanced visibility to U.S. investors interested in precision cancer therapeutics. For a biotech firm focused on challenging areas like targeted brain delivery, market accessibility is crucial for sustained growth and development. With the new trading platform,…

Read More >>

CBIZ (NYSE: CBZ) Reports Rising AI Momentum Amid Upskilling Efforts

May 14, 2026

Expert Analysis CBIZ, Inc. (NYSE: CBZ) is observing a significant shift in how mid-market companies are approaching artificial intelligence integration and workforce development. The challenge lies less in accessing AI technology and more in preparing their teams to utilize it effectively. This trend underscores the critical need for targeted upskilling as a fundamental step toward successful AI execution. For CBIZ, Inc. (NYSE: CBZ), these insights reveal important implications for professional…

Read More >>

AiRWA Inc. (NASDAQ: YYAI) Announces 1-for-40 Reverse Stock Split

May 14, 2026

Expert Analysis The decision by AiRWA Inc. (NASDAQ: YYAI) to proceed with a 1-for-40 reverse stock split carries significant implications for the company’s capital structure and investor perception. This maneuver typically aims to consolidate shares to increase the market price per share, potentially reducing volatility and meeting listing standards on the NASDAQ exchange. For investors, this reverse split will adjust share quantities but not the proportional ownership or the intrinsic…

Read More >>

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advances Drug Delivery Against BBB Challenge

May 14, 2026

Expert Analysis Oncotelic Therapeutics Inc. (OTCQB: OTLC) is making significant strides in tackling the persistent challenge of delivering drugs across the blood-brain barrier (BBB). As many neurological conditions remain difficult to treat due to the protective nature of the BBB, developing innovative delivery platforms is crucial. OTLC’s novel approach positions the company as a potential leader in overcoming this long-standing obstacle in drug development. The implications of successfully crossing the…

Read More >>